According to Geron's latest financial reports the company's current earnings (TTM) are -$0.18 B. a decrease over its 2022 earnings that were of -$0.14 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$0.18 B | 30.22% |
2022 | -$0.14 B | 20.15% |
2021 | -$0.12 B | 50.08% |
2020 | -$74.88 M | 4.46% |
2019 | -$71.68 M | 130.68% |
2018 | -$31.08 M | 8.84% |
2017 | -$28.55 M | -3.08% |
2016 | -$29.46 M | -22080.6% |
2015 | $0.13 M | -100.38% |
2014 | -$35.59 M | -7.14% |
2013 | -$38.33 M | |
2011 | -$90.67 M | 19.04% |
2010 | -$76.17 M | 8.45% |
2009 | -$70.24 M | -2.51% |
2008 | -$72.05 M | 14.65% |
2007 | -$62.84 M | 32.68% |
2006 | -$47.36 M | 25.59% |
2005 | -$37.71 M | 4.36% |
2004 | -$36.14 M | 19.73% |
2003 | -$30.18 M | -15.46% |
2002 | -$35.7 M | 1.94% |
2001 | -$35.02 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Gilead Sciences GILD | $6.85 B | -4,001.26% | ๐บ๐ธ USA |
Incyte INCY | $0.83 B | -574.48% | ๐บ๐ธ USA |
CTI BioPharma
CTIC | -$69.24 M | -60.62% | ๐บ๐ธ USA |
Bio-Techne TECH | $0.26 B | -251.15% | ๐บ๐ธ USA |
Eterna Therapeutics ERNA | -$20.53 M | -88.33% | ๐บ๐ธ USA |